Default: JCO Precision Oncology

ISSN: 2473-4284

Journal Home

Journal Guideline

JCO Precision Oncology Q1 Unclaimed

Lippincott Williams and Wilkins United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

JCO Precision Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 48. It has an SJR impact factor of 2,249 and it has a best quartile of Q1. It has an SJR impact factor of 2,249.

JCO Precision Oncology focuses its scope in these topics and keywords: clinical, mutations, metastatic, therapy, patient, oncology, tumor, lung, smallcell, growth, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

JCO Precision Oncology

2,249

SJR Impact factor

48

H Index

0

Total Docs (Last Year)

395

Total Docs (3 years)

0

Total Refs

1632

Total Cites (3 years)

356

Citable Docs (3 years)

4.46

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


clinical, mutations, metastatic, therapy, patient, oncology, tumor, lung, smallcell, growth, genomedriven, cancerconcurrent, journey, mek, melanoma, nonv, oncologysignificant, fusiontargeted, factor, epidermal, automated, braf, breast, cancers, cells, ceritinibresistant, circulating, colorectal, crizotinib, egfr, emergence,

FAQS